Dr. Libby is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
77 Avenue Louis Pasteur
NRB 741
Boston, MA 02115Phone+1 617-525-4351
Summary
- Dr. Peter Libby is a cardiologist in Boston, MA and is affiliated with Brigham and Women's Hospital. He received his medical degree from University of California San Diego School of Medicine and has been in practice 44 years. He specializes in preventive cardiology and is experienced in general cardiology. He has a research interest in atherosclerosis and other vascular diseases, in particular the role of inflammation.
Education & Training
- Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1979 - 1980
- Brigham and Women's HospitalResidency, Internal Medicine, 1973 - 1976
- University of California San Diego School of MedicineClass of 1973
Certifications & Licensure
- CA State Medical License 1976 - 2027
- MA State Medical License 1976 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1987
- Super Doctor SuperDoctors.com
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- Plaque erosion risk and JAK2 V617F variant.Shengfang Wang, Xing Luo, Sining Hu, Chen Zhao, Qianhui Sun
European Heart Journal. 2025-03-07 - 1 citationsCarotid artery atherosclerosis: mechanisms of instability and clinical implications.Luca Saba, Riccardo Cau, Rocco Vergallo, M Eline Kooi, Daniel Staub
European Heart Journal. 2025-03-07 - Emerging Pathways of Action of Eicosapentaenoic Acid (EPA).Deepak L Bhatt, Peter Libby, R Preston Mason
JACC. Basic to Translational Science. 2025-03-01
Journal Articles
- Inflammation, Immunity, and Infection in AtherothrombosisPaul M Ridker, Valentin Fuster, Priscilla Y Hsue, Peter Libby, ScienceDirect
- Relationship of Interleukin-1β Blockade with Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled TrialDaniel H Solomon, Paul M Ridker, Brendan M Everett, Peter Libby, Annals of Internal Medicine
- Modulation of the Interleukin-6 Signalling Pathway and Incidence Rates of Atherosclerotic Events and All-Cause Mortality: Analyses from the Canakinumab Anti-Inflammato...Paul M Ridker, Brendan M Everett, Christie Ballantyne, Peter Libby, European Heart Journal
Authored Content
- A Review of 'Inflammation Drives Atherosclerosis from Beginning to End'April 2022
Press Mentions
- Cover Story | Transformative Trends in CV Medicine for 2025January 6th, 2025
- Feature | a Nobel for Advancing CV Medicine?January 6th, 2025
- The 'Plaque Hypothesis': Focus on Vulnerable Lesions to Cut EventsDecember 20th, 2022
- Join now to see all
Grant Support
- Role of CLCA1 as a MIF decoy inhibitor in abdominal aortic aneurysmsBRIGHAM AND WOMEN'S HOSPITAL2024–2028
- Role of CLCA1 as a MIF decoy inhibitor in abdominal aortic aneurysmsBRIGHAM AND WOMEN'S HOSPITAL2024–2028
- Role of eosinophil cationic proteins in cardiac hypertrophyBRIGHAM AND WOMEN'S HOSPITAL2023–2027
- Role of eosinophil cationic proteins in cardiac hypertrophyBRIGHAM AND WOMEN'S HOSPITAL2023–2027
- Role of eosinophil cationic proteins in cardiac hypertrophyBRIGHAM AND WOMEN'S HOSPITAL2023–2027
- Role of eosinophil cationic proteins in cardiac hypertrophyBRIGHAM AND WOMEN'S HOSPITAL2023–2027
- Role of eosinophil cationic proteins in cardiac hypertrophyBRIGHAM AND WOMEN'S HOSPITAL2023–2027
- Mechanisms and Modulation of Accelerated Atherosclerosis in Clonal HematopoiesisBRIGHAM AND WOMEN'S HOSPITAL2022–2026
- Role of group 2 innate lymphoid cells in myocardial infarctionBRIGHAM AND WOMEN'S HOSPITAL2021–2025
- Role of group 2 innate lymphoid cells in myocardial infarctionBRIGHAM AND WOMEN'S HOSPITAL2021–2025
- Role of group 2 innate lymphoid cells in myocardial infarctionBRIGHAM AND WOMEN'S HOSPITAL2021–2025
- Role of group 2 innate lymphoid cells in myocardial infarctionBRIGHAM AND WOMEN'S HOSPITAL2021–2025
- Role of group 2 innate lymphoid cells in myocardial infarctionBRIGHAM AND WOMEN'S HOSPITAL2021–2025
- Role of group 2 innate lymphoid cells in myocardial infarctionBRIGHAM AND WOMEN'S HOSPITAL2021–2025
- Role of Mast cells in Alzheimer's DiseaseBRIGHAM AND WOMEN'S HOSPITAL2020–2025
- Training Grant in Cardiovascular ResearchBRIGHAM AND WOMEN'S HOSPITAL1985–2025
- Training Grant in Cardiovascular ResearchBRIGHAM AND WOMEN'S HOSPITAL1985–2025
- Training Grant in Cardiovascular ResearchBRIGHAM AND WOMEN'S HOSPITAL1985–2025
- Training Grant in Cardiovascular ResearchBRIGHAM AND WOMEN'S HOSPITAL1985–2025
- Training Grant in Cardiovascular ResearchBRIGHAM AND WOMEN'S HOSPITAL1985–2025
- Role of ILC2 and eosinophils in abdominal aortic aneurysmBRIGHAM AND WOMEN'S HOSPITAL2021–2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: